NewLimit raised $435M in Series C funding led by Founders Fund to advance its first age-reprogramming drug into human trials.News, Brian Armstrong, CoinbaseRead More
You might also be interested in reading Bodies of husband and wife taken into Gaza by Hamas recovered by Israeli forces.
